Infectious diseases remain a significant cause of morbidity and mortality in many African countries; with the resulting socio-economic consequences contributing to productivity losses and hence slowed ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Copyright: © 2024 The Authors. Published by Elsevier B.V. Emerging pathogens are global public health threats and pose unique challenges for vaccine development ...

Varicella-zoster virus causes chickenpox and is a member of the herpes virus group. It is extremely contagious and causes a ...

Belfast, Maine: Let us not make momentous decisions based on anger. Doing so has started many wars that hurt all involved, forever. Government has always been corrupted by money and the power that ...

Growth at the vaccines business was driven in part by the rollout of Beyfortus, a shot that protects babies from respiratory syncytial virus (RSV). Merck also has a rival monoclonal antibody shot in ...

Cohen's research is waiting for peer review and publication. There is a vaccine for shingles that's more than 90% effective but only about a quarter of eligible adults get it. "I'm hoping that we ...

Sanofi profit rose on demand for seasonal vaccines and further growth in its blockbuster skin and asthma therapy Dupixent. Earnings per share excluding some items reached €2.86 ($3.10) in the third ...

Growth at the vaccines business was driven in part by the rollout of Beyfortus, a shot that protects babies from RSV. Merck & Co. also has a rival monoclonal antibody shot in development for RSV.

(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected ... a poll posted on the company's website. Vaccines sales rose a currency-adjusted ...